CompletedNCT01080521
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
Studying Malignant mixed Müllerian tumor of the ovary
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Lisa HessGynecologic Oncology Group
- Intervention
- Cognitive Assessment(procedure)
- Enrollment
- 247 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2010 – 2018
Study locations (30)
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
- Roy and Patricia Disney Family Cancer Center, Burbank, California, United States
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States
- University of California San Diego, San Diego, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora, Colorado, United States
- Hartford Hospital, Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
- The Hospital of Central Connecticut, New Britain, Connecticut, United States
- Florida Hospital Orlando, Orlando, Florida, United States
- John B Amos Cancer Center, Columbus, Georgia, United States
- Northeast Georgia Medical Center, Gainesville, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01080521 on ClinicalTrials.govOther trials for Malignant mixed Müllerian tumor of the ovary
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06483048MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian CancerMayo Clinic
- RECRUITINGPHASE2, PHASE3NCT03651206Recurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibARCAGY/ GINECO GROUP
See all trials for Malignant mixed Müllerian tumor of the ovary →